Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (DGX) Stock Overview
Explore Quest Diagnostics Incorporated’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
22B
P/E Ratio
22.16
EPS (TTM)
$8.75
ROE
0.14%
DGX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Quest Diagnostics Incorporated (DGX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 49.79, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $186.36.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 22.16 and a market capitalization of 22B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.